Greece’s is set to get its first vaccine production facility courtesy of the Pasteur Institute said its Athens branch Director General Dr. Stathis Gonos during an interview with Greek media on Saturday.
According to the Director General of the Athens-based Hellenic Pasteur Institute, this will be made possible with the financial help of the Stavros Niarchos Foundation (SNF), adding that the SNF essentially funds the renovation of the building and its equipment.
The scientific activities relate to Pasteur’s research team with technical and administrative support staff, adding that in addition to the production of vaccines, there will be bottling to third parties, so that “we have the opportunity, finally in Greece, to start clinical trials.
That is, to make vaccines, which will be used in clinical trials, in phases 1,2,3, so that later we can have some innovative drugs. The unit is to be completed within 2022, and we estimate that the final licensing by (EOF) will probably take place in the next 12-18 months. We hope to be formally ready to start the production of vaccines in the beginning of 2023.”